AGI Therapeutics

AGI Therapeutics was a specialty pharmaceutical company that was focused on the development and commercialisation of specialty drug products.

The company completed an IPO in 2006 and was subsequently acquired by Vidara Therapeutics.

Peter Sandys

Managed by

Peter Sandys

Managing Partner

We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top